Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 2,554

Document Document Title
WO/2007/091716A1
An optical film, which has been subjected to an orientation treatment, containing a low-molecular weight compound, in which a birefringence Δn(550 nm) is larger than zero (0) in an orientation direction, and the optical film satisfies t...  
WO/2007/068745A1
The invention concerns novel polyunsaturated compounds of formula (I) wherein: R1 represents a R'1, -A-R'1 group, R'1 being selected among - COOH, -COOR3, -CONH2, -CONHR3, -CONR3 R4, -CHO, -CH2OH, -CH2OR5, and A represents a C2-C16 alkyl...  
WO2006119758B1
The invention relates to dihydroxyphenylalanine derivatives, the production thereof, and pharmaceutical compositions containing said dihydroxyphenylalanine derivatives. The invention further relates to the use of said dihydroxyphenylalan...  
WO/2007/049736A1
This invention provides a process for producing a natural product having stable quality with high recovery. There is also provided a method for concentration-crystallizing a natural product, characterized by comprising continuously measu...  
WO/2007/049658A1
A dithianedithiol derivative represented by the following general formula (1): (wherein R represents hydrogen or acyl; and X represents a C1-12 divalent hydrocarbon group which may have a substituent not participating in reactions and ma...  
WO/2007/035735A1
The invention features compositions comprising at least one monomer that comprises a cyclic dithiane moiety attached to a (meth)acryloyl moiety. The composition may optionally contain additional polymerizable compounds, such as ethylenic...  
WO/2007/032362A1
It is intended to provide a substituted cycloalkene derivative represented by the general formula (I) which has an action of suppressing intracellular signal transduction or cell activation caused by endotoxin and a cell response such as...  
WO/2006/119758A3
The invention relates to dihydroxyphenylalanine derivatives, the production thereof, and pharmaceutical compositions containing said dihydroxyphenylalanine derivatives. The invention further relates to the use of said dihydroxyphenylalan...  
WO/2007/015412A1
Disclosed is an organic electroluminescent device (organic EL device) of simple structure which is improved in luminous efficiency and sufficiently secured in driving stability. Also disclosed is a heterocyclic compound used for such an ...  
WO/2006/134282A1
The invention concerns a cosmetic, therapeutic, in particular dermatological, bioprecursor of formula [A]n -PP - [B]m wherein: PP represents a polyphenol radical where each hydroxyl function is protected by a group A or a group B; A is a...  
WO/2006/134489A1
The present invention relates to novel non steroidal anti-inflammatory compounds (NSAIDs) derivatives of sulindac, for the treatment/prevention, alone or in combination, of cancer.  
WO/2006/125295A1
The present invention provides new derivatives of 4-or 5-aminosalicylic acid, and a pharmaceutical composition containing these derivatives of 4-or 5-aminosalicylic acid as active ingredients, useful for the treatment of intestinal disea...  
WO/2006/126415A1
A sulfur-containing cycloolefin resin of 1000 to 1,000,000 weight average molecular weight comprised of any of units of the general formula (1): wherein each of R1 to R6 independently is a hydrogen atom, a C1-C20 alkyl, a C1-C20 aralkyl,...  
WO2006079112A3
This invention provides a method of synthesizing enantioenriched merrilactone A and enantiopure merrilactone A, as well as an improved method of synthesizing racemic merrilactone. This invention also provides intermediate compounds and m...  
WO/2006/125293A1
The present invention provides new derivatives of 4- or 5-aminosalicylic acid, and a pharmaceutical composition containing these derivatives of 4- or 5-aminosalicylic acid as active ingredients, useful for the treatment of intestinal dis...  
WO/2006/119758A2
The invention relates to dihydroxyphenylalanine derivatives, the production thereof, and pharmaceutical compositions containing said dihydroxyphenylalanine derivatives. The invention further relates to the use of said dihydroxyphenylalan...  
WO/2006/117995A1
A therapeutic agent for loss of scalp hair comprising a lipoic acid or a lipoic acid derivative represented by the formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient: (1) wherein R represents an OH group, a...  
WO2006036941A3
Resorcylic acid lactones having a C5-C6 cis double bond and a ketone at C7 and other compounds capable of Michael adduct formation are potent and stable inhibitors of a subset of protein kinases having a specific cysteine residue in the ...  
WO2006089861A3
The invention relates to dithiolethiones derivatives as monoamino oxidase inhibitors, in particular MAO-B inhibitors, to methods for the preparation of these compounds and to novel intermediates useful for the synthesis of said dithiolet...  
WO/2006/111791A1
The present invention relates to novel non steroidal anti-inflammatory compounds (NSAIDs) that release hydrogen sulfide (H2S). The present invention also provides methods for treating, preventing and/or reducing inflammation-associated d...  
WO/2006/110221A1
Various non-limiting embodiments disclosed herein relate to photochromic materials having extended pi-conjugated systems. For example, various non-limiting embodiments disclosed herein provide a photochromic material, such as an indeno-f...  
WO2006014219A3
A process for the manufacture of new stable, crystalline salts of N-[2-(dimethylamino)-ethyl]-1,2-dithiolane-3-pentanamide (racemic and chiral forms) with good water solubility that are useful as antioxidant compounds and effectively inh...  
WO/2006/100229A1
Process for purifying thioctic acid in water comprising the following steps: a) dissolving the thioctic acid in an aqueous alkaline solution or alternatively dissolving a thioctic acid salt, if necessary adjusting the pH to alkaline valu...  
WO2005037257A3
The invention relates to medicinally used substances which specifically inhibit peptidases splitting ala-p-nitroanilide. The invention further relates to the use of at least one such substance or at least one pharmaceutical or cosmetic c...  
WO2005075453A9
A novel linker compound that minimizes any nonspecific hydrophobic interactions and is capable of easily regulating the length to disulfide group subjected to metal bond to thereby enable efficient formation of metal-sulfur bond; a novel...  
WO/2006/089861A2
The invention relates to dithiolethiones derivatives as monoamino oxidase inhibitors, in particular MAO-B inhibitors, to methods for the preparation of these compounds and to novel intermediates useful for the synthesis of said dithiolet...  
WO2006028977A3
The present invention provides a chiral ligand, represented by a formula or its enantiomer: formula (I) X and X' can be independently O, NH, NR, NCOR or S; each of Z1-Z7 and Z1'-Z7' can be independently H, alkyl, aryl, substituted alkyl,...  
WO/2006/085510A1
A remedy for IBS comprising, as the active ingredient, a dual antagonist for 5-HT2B and 5-HT7 receptors which shows selective binding affinities to 5-HT2B and 5-HT7 receptors. The above-described medicinal composition is superior in the ...  
WO2004078908A3
The present invention relates to novel a-keto carbonyl calpain inhibitors for the treatment of neurodegenerative diseases and neuromuscular diseases including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and other muscular dyst...  
WO/2006/066894A1
Compounds of general formula (I), wherein R’, R, x and z have the meaning reported in the specification, are useful for treating inflammatory diseases including metabolic syndrome, diabetes, obesity, dyslipidemia, and insulin resistance.  
WO2006047011A3
Fuels, especially hydrocarbon fuels, and lubricants, especially lubricating oils, contain a class of anti-corrosion, anti-wear, anti-fatigue, and extreme pressure additives that are derived from 1,3-dithiolane-2-thiones.  
WO2006048911A3
Compositions to be incorporated in products with hypoglycemizing, anti-oxidant, vasoprotective and anti-hyperlipemic activity, or in products recommended for the treatment of anaemias and states or iron deficiency, the compositions being...  
WO2006044379A3
The present invention relates to compounds capable of acting as androgen receptor, antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agen...  
WO/2006/048911A2
Compositions to be incorporated in products with hypoglycemizing, anti-oxidant, vasoprotective and anti-hyperlipemic activity, or in products recommended for the treatment of anaemias and states or iron deficiency, the compositions being...  
WO/2006/047011A2
Fuels, especially hydrocarbon fuels, and lubricants, especially lubricating oils, contain a class of anti-corrosion, anti-wear, anti-fatigue, and extreme pressure additives that are derived from 1,3-dithiolane-2-thiones.  
WO/2006/044379A2
The present invention relates to compounds capable of acting as androgen receptor, antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agen...  
WO/2006/029532A1
Nitrate esters and methods for mitigating neurodegeneration, affecting neuroprotection, affecting cognition enhancement, and/or preventing or mitigating tissue and/or cellular damage in a subject are described. Neurological or cognitive ...  
WO/2006/021282A1
The invention relates to novel compounds containing at least one multiple bond that is excited by irradiation with polarised light and thus produces an anisotropy in films containing said compounds or amplifies an already existing anisot...  
WO/2006/021413A1
The present invention relates to novel &agr -keto carbonyl calpain inhibitors for the treatment of neurodegenerative diseases and neuromuscular diseases including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and other muscular ...  
WO2005079378A3
Synthetic methods and intermediates useful in the preparation of lactone containing compounds such as discodermolide and compounds which mimic the chemical or biological activity of discodermolide are provided.  
WO/2006/014219A2
A process for the manufacture of new stable, crystalline salts of N-[2-(dimethylamino)-ethyl]-1,2-dithiolane-3-pentanamide (racemic and chiral forms) with good water solubility that are useful as antioxidant compounds and effectively inh...  
WO2002046150A3
Compounds which mimic the chemical and/or biological activity of discodermolide are provided and intermediates useful in their preparation.  
WO/2005/095941A1
A mass analysis method for a derivative of an organic residue containing a sulfur atom, characterized in that it comprises ionizing a derivative of an organic residue containing said sulfur atom from a metal-organic residue composite whe...  
WO/2005/085186A1
Disclosed is a method for producing an isocyanate compound through reaction between a carbonate of a corresponding amine compound and phosgene, wherein phosgene is introduced into an organic solvent solution of the carbonate of the amine...  
WO/2005/079845A1
Preventives for migraine which contain, as the active ingredient, a double antagonist to 5-HT2B and 5-HT7 receptors having selective binding affinities for the 5-HT2B and 5-HT7 receptors. These preventives for migraine show a favorable p...  
WO/2005/080322A1
A novel fluorene characterized by having a fluorene skeleton to which a functional group such as a guanidino group is attached via a carbonyl group, or its salt. This compound has such an advantage as showing a high affinity particularly...  
WO/2005/079378A2
Synthetic methods and intermediates useful in the preparation of lactone containing compounds such as discodermolide and compounds which mimic the chemical or biological activity of discodermolide are provided.  
WO/2005/075453A1
A novel linker compound that minimizes any nonspecific hydrophobic interactions and is capable of easily regulating the length to disulfide group subjected to metal bond to thereby enable efficient formation of metal-sulfur bond; a novel...  
WO/2005/073184A1
The invention relates to substituted 1,3-diphenylprop-2-en-1-one derivative compounds, pharmaceutical and/or cosmetic compositions containing same, and the applications thereof in therapeutics and cosmetics. The invention also relates to...  
WO/2005/068415A1
Disclosed is a phenylalanine derivative having excellent VLA-4 inhibitory activity which is represented by the following general formula (1) or a salt thereof. (1) (In the formula, R1 represents an aromatic hydrocarbon group having 6-10 ...  

Matches 201 - 250 out of 2,554